FDA Inspection
Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. – FDA Inspection, Mar 21, 2025
Record Details
This FDA Inspection record concerns Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd., with an inspection on March 21, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 21, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 9bf7f948-342a-4011-b6e1-5f0b70bdda6c
Inspection Facts
- Inspection number
- 1266237
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 2, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2018 | Not classified | Office of Inspections and Investigations | |
| September 29, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd.
- FDA Inspection 1155300 - 2019-08-02
- FDA Inspection 1041618 - 2018-02-02
- FDA Inspection 989767 - 2016-09-29
- FDA Inspection 854635 - 2013-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.